Mediphage Bioceuticals
PrivateLast Round
Grant
Jan 6, 2026
Total Funding Raised
$3.41M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mediphage Bioceuticals operates in Healthcare & Life Sciences and is based in Toronto, Ontario. Its latest recorded funding round was a Seed round in February 2024.
Mediphage Bioceuticals is a biotechnology company that develops a non-viral gene therapy platform called ministring DNA (msDNA) for applications in gene therapy, cell engineering, and DNA vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mediphage Bioceuticals Comparables
Compare Mediphage Bioceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Touchlight | 78% | |
| Myosana Therapeutics | 77% | |
| Generation Bio | 77% |
For institutional investors. Book with your work email.
Mediphage Bioceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 6, 2026 | ||||
| Seed | Feb 7, 2024 | ||||
| Seed | Dec 16, 2021 | ||||
| Grant | Jun 15, 2020 | ||||
| Seed | Jul 15, 2019 | ||||
Accelerator | Apr 26, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mediphage Bioceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Innovate UK | Grant |
| CCRM Enterprises Inc. | Seed |
| Riverine Ventures | Seed |
| Illumina Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 75% MoM.
- Jan 27, 2026
Monthly visitors grew 1820% MoM, from 35 to 672.
For institutional investors. Book with your work email.
Mediphage Bioceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mediphage Bioceuticals's valuation, stock price, and market status.
Is Mediphage Bioceuticals a public or private company?
Mediphage Bioceuticals is a private company.
What is the current stock price of Mediphage Bioceuticals?
Mediphage Bioceuticals is a private company, so its shares have no public market price. Caplight tracks Mediphage Bioceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mediphage Bioceuticals worth (valuation)?
Valuation information for Mediphage Bioceuticals is not publicly available.
Can I buy Mediphage Bioceuticals stock?
Mediphage Bioceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mediphage Bioceuticals's last funding round?
Mediphage Bioceuticals's most recent funding round was Grant on January 6, 2026.
Who are the main investors in Mediphage Bioceuticals?
Key investors in Mediphage Bioceuticals include CCRM Enterprises Inc., Illumina Accelerator.
Will Mediphage Bioceuticals IPO soon?
No public IPO plans have been announced for Mediphage Bioceuticals.
How can I track Mediphage Bioceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Mediphage Bioceuticals's shares on secondary markets.